Yusupov, A. F., et al. “The Short-Term Efficacy of a Monoclonal Antibody Fragment (brolucizumab) for Treating Neovascular Age-Related Macular Degeneration”. Journal of Ophthalmology (Ukraine), no. 3, July 2024, pp. 28-32, doi:10.31288/oftalmolzh202432832.